|
Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies |
|
|
|
Title: |
Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies |
Author: |
Finn, Richard S. Gu, Kangsheng Chen, Xi Merle, Philippe Lee, Kyung-Hun Bouattour, Mohamed Cao, Peiguo Wang, Wei Cheng, Ann-Lii Zhu, Liangjun Lim, Ho Yeong Kudo, Masatoshi Pan, Yueyin Chang, Ting-Tsung Edeline, Julien Li, Wei Yang, Ping Li, Chen Li, Jianfeng Siegel, Abby B. Qin, Shukui |
Appeared in: |
JHEP reports |
Paging: |
Volume 7 () nr. 6 pages p. |
Year: |
2025 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|